Last Updated: June 19, 2026

Suppliers and packagers for sulfamylon


✉ Email this page to a colleague

« Back to Dashboard


sulfamylon

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Rising SULFAMYLON mafenide acetate CREAM;TOPICAL 016763 NDA Rising Pharma Holdings, Inc. 16571-723-12 1 TUBE in 1 CARTON (16571-723-12) / 113.4 g in 1 TUBE 2020-05-18
Rising SULFAMYLON mafenide acetate CREAM;TOPICAL 016763 NDA Rising Pharma Holdings, Inc. 16571-723-48 453.6 g in 1 JAR (16571-723-48) 2020-05-18
Rising SULFAMYLON mafenide acetate CREAM;TOPICAL 016763 NDA Rising Pharma Holdings, Inc. 16571-723-60 1 TUBE in 1 CARTON (16571-723-60) / 56.7 g in 1 TUBE 2020-05-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for sulfamylon

Last updated: May 26, 2026

Sulfamylon suppliers: who manufactures silver sulfadiazine (and where does procurement come from)?

Suppliers for sulfamylon typically mean suppliers of silver sulfadiazine (the active ingredient) and distributors that carry sulfamylon brand/generic equivalents. The procurement map is split into (1) API and finished-dose manufacturers for silver sulfadiazine creams and (2) authorized wholesalers and healthcare distributors that ship finished product into specific geographies.

Named supply reality for “sulfamylon”

  • Sulfamylon is a brand name used for silver sulfadiazine topical antimicrobial creams/ointments (burn and wound indications).
  • In practice, supply comes from a mix of:
    • Brand holders’ finished-dose supply chains (where the brand product is still marketed)
    • Generic silver sulfadiazine manufacturers for the same dosage forms
    • API suppliers supplying contract manufacturers that formulate the cream

Because “sulfamylon” is a brand term and availability is geography- and formulation-dependent, procurement due diligence usually targets strength, dosage form (cream vs. ointment), concentration (commonly 1%), and packaging (tube size), plus regulatory status (approved NDA/ANDA and labeling).


Which companies supply sulfamylon (silver sulfadiazine cream) in the US and EU?

Featured snippet answer: Sulfamylon supply is typically provided by generic silver sulfadiazine manufacturers (1% topical cream) and authorized distributors, with company names varying by country and product strength/package.

US supply channels: brand vs. generic

In the US, topical silver sulfadiazine 1% products are commonly sourced via:

  • ANDA-approved generic manufacturers of silver sulfadiazine cream
  • Authorized distributors that list NDC-specific SKUs

Procurement teams usually build a vendor list at the NDC + strength + tube size level rather than by brand name.

EU supply channels

In Europe, supply is usually:

  • Finished-dose manufacturers of silver sulfadiazine cream marketed under brand or generic labels
  • Wholesalers that distribute through local tender and hospital pharmacy procurement

EU sourcing similarly depends on:

  • Product presentation (cream formulation)
  • SmPC labeling for wound/burn use
  • Local marketing authorization status

What are the most common supplier categories for silver sulfadiazine (sulfamylon) products?

Featured snippet answer: Procurement typically breaks into three supplier categories: API suppliers, finished-dose manufacturers, and authorized wholesalers/distributors.

1) API suppliers (silver sulfadiazine)

API supply supports:

  • Contract manufacturing organizations (CMOs)
  • Finished-dose manufacturers that formulate creams/ointments

Key diligence items:

  • API CoA, particle size specs, impurity profiles
  • GMP site capability for pharmaceutical grade silver sulfadiazine
  • Traceability and change-control compliance

2) Finished-dose manufacturers (cream/ointment)

This is the practical category for hospital procurement:

  • Silver sulfadiazine 1% cream (and in some markets, ointment)
  • Packaging compliant with local regulations

Key diligence items:

  • Formulation equivalence (cream base)
  • Sterility/bioburden controls where applicable to packaging
  • Stability and shelf-life under labeled storage conditions

3) Wholesalers and healthcare distributors

These vendors supply hospitals and clinics:

  • Tender fulfillment
  • Cold-chain is usually not required for standard silver sulfadiazine creams, but storage conditions still matter
  • Multiple SKUs may exist by NDC/pack size

Where can you buy sulfamylon: hospital distributors, online pharmacies, or wholesalers?

Featured snippet answer: In most healthcare procurement settings, sulfamylon is purchased through authorized healthcare distributors using product IDs (NDC in the US, MA number in the EU), not through direct-to-patient retail channels.

Institutional procurement (typical workflow)

  • Pharmacy group purchasing organizations (GPOs)
  • Hospital group purchasing
  • Distributor catalog ordering by SKU

Retail/online procurement (typical constraints)

  • Product may be sourced from multiple manufacturers
  • Brand labeling may differ by market
  • Substitution rules depend on local policy and procurement contracts

What dosage form and strength matter when sourcing sulfamylon?

Featured snippet answer: Confirm silver sulfadiazine strength (commonly 1%) and topical dosage form (cream vs ointment) before selecting a supplier.

Common product specification filters

  • Active ingredient: silver sulfadiazine
  • Strength: typically 1% (w/w)
  • Dosage form: cream or ointment
  • Packaging: tube size (varies by market)
  • Intended indication per labeling (burn/wound)

What sourcing risks exist for sulfamylon (silver sulfadiazine) procurement?

Featured snippet answer: Main risks are manufacturer concentration, substitution quality, supply interruptions, and SKU drift (different base/packaging).

Practical risk vectors

  • API supply disruptions can cascade into finished-dose shortages
  • Some SKUs may be discontinued or temporarily unavailable
  • Generic substitutions may change excipients and texture, affecting clinician acceptance

Mitigation used in procurement

  • Multi-sourcing at the SKU/spec level
  • Contract clauses for supply continuity and quality documentation
  • Incoming CoA and batch release verification

How does sulfamylon compare with alternative topical antimicrobials for procurement?

Featured snippet answer: Silver sulfadiazine competes with other topical agents used in burns and wound care. Substitution decisions depend on clinical protocol, resistance patterns, and supply availability.

Adjacent procurement alternatives (by therapeutic use)

  • Other topical antimicrobials
  • Silver-based wound products (non-sulfadiazine formulations)
  • Non-silver antiseptics or dressings

Procurement teams usually validate:

  • Formulary position
  • Tender price
  • Stockout risk
  • Expected shelf life and storage stability

Who are the typical “supplier names” you’ll see on purchase orders?

Featured snippet answer: PO vendors usually show up as either:

  1. a finished-dose manufacturer (on-label MAH/NDA holder) or
  2. a distributor/wholesaler fulfilling the SKU.

Because supplier names vary by geography and NDC/MA presentation, procurement lists are best maintained by:

  • Product identifier (NDC/GTIN/pack)
  • Manufacturer labeler and manufacturing site (where available)
  • Distributor account used for the hospital’s procurement model

Key Takeaways

  • “Sulfamylon” procurement is, in practice, procurement of silver sulfadiazine topical (commonly 1% cream) plus its specific SKU presentation.
  • Supply sources split into API suppliers, finished-dose manufacturers, and authorized healthcare distributors.
  • Vendor selection should be done at the dose form + strength + packaging + product identifier level to avoid SKU drift and substitution risk.
  • Stock continuity depends on finished-dose manufacturer capacity and upstream API availability.

FAQs

  1. What is sulfamylon active ingredient and what does that mean for supplier matching?
    Sulfamylon is a brand for silver sulfadiazine, so suppliers are matched by silver sulfadiazine 1% topical specs.

  2. How do I source silver sulfadiazine cream for hospitals if the brand is unavailable?
    Source the approved generic silver sulfadiazine cream matching strength and presentation and buy through authorized distributors.

  3. Can I substitute silver sulfadiazine ointment for cream without changing procurement quality?
    No. Ointment vs cream can differ in excipients and performance; procurement should match the exact dosage form used in the protocol.

  4. What documentation should accompany sulfamylon/silver sulfadiazine shipments?
    Expect CoA, batch/lot traceability, and labeled specs for strength, shelf life, storage conditions, and packaging.

  5. What supply chain bottlenecks most often impact silver sulfadiazine topical products?
    The most common bottlenecks are upstream API supply and finished-dose manufacturer capacity, leading to SKU shortages.


References (APA)

No sources cited.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.